[1] |
OKUMURA T, KAWADA J, TANAKA M, et al.Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children[J].J Infect Chemother, 2019, 25(5):346. |
[2] |
SHAN LS, LIU X, KANG XY, et al.Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children[J].World J Pediatr, 2017, 13(4):321. doi: 10.1007/s12519-017-0014-9 |
[3] |
LIU JR, PENG Y.Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia[J].Chinese J Pediatr, 2012, 50(12):915. |
[4] |
许姜姜, 舒林华.儿童难治性肺炎支原体肺炎临床特征分析[J].中国当代儿科杂志, 2018, 20(1):37. |
[5] |
卫计委.糖皮质激素类药物临床应用指导原则[S].2011-02-24. |
[6] |
NILSSON AC, BJÖRKMAN P, WELINDER-OLSSON C, et al.Clinical severity of Mycoplasma pneumoniae (MP) infection is associated with bacterial load in oropharyngeal secretions but not with MP genotype[J].BMC Infect Dis, 2010, 10:39. doi: 10.1186/1471-2334-10-39 |
[7] |
郑宝英, 闫超, 薛冠华.耐药肺炎支原体肺炎患儿的临床特点及流行基因型特征分析[J].中华实用儿科临床杂志, 2017, 32(10):735. doi: 10.3760/cma.j.issn.2095-428X.2017.10.005 |
[8] |
ZHANG XX, CHEN ZR, GU WJ, et al.Viral and bacterial co-infection in hospitalised children with refractory Mycoplasma pneumoniae pneumonia[J].Epidemiol Infect, 2018, 146(11):1384. doi: 10.1017/S0950268818000778 |
[9] |
YOU SY, JWA HJ, YANG EA, et al.Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children[J].Allergy Asthma Immunol Res, 2014, 6(1):22. doi: 10.4168/aair.2014.6.1.22 |
[10] |
常宇娟.糖皮质激素在儿童难治性支原体肺炎中的疗效观察[J].实用临床医药杂志, 2018, 22(3):117. |
[11] |
陈莉莉, 刘金荣, 赵顺英.常规剂量甲泼尼龙治疗无效的儿童难治性肺炎支原体肺炎的临床特征和治疗探讨[J].中华儿科杂志, 2014, 152(3):172. doi: 10.3760/cma.j.issn.0578-1310.2014.03.003 |
[12] |
孙立平, 王助衡, 洪翠翠.注射用甲基泼尼松龙冲击疗法治疗小儿难治性支原体肺炎疗效分析[J].临床儿科杂志, 2014, 32(10):996. doi: 10.3969/j.issn.1000-3606.2014.10.025 |
[13] |
LIU JR, LU JIE, LI DF, et al.Low bacterial co-infection invalidates the early use of non-anti-Mycoplasma pneumoniae antibiotics in pediatric refractory Mycoplasma pneumoniae pneumonia patients[J].Front Pediatr, 2018, 6:296. doi: 10.3389/fped.2018.00296 |
[14] |
SEO YH, KIM JS, SEO SC, et al.Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant pneumonia[J].Korean J Pediatr, 2014, 57(4):186. |
[15] |
LIU TY, LEE WJ, TSAI CM, et al.Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children[J].Pediatr Neonatol, 2018, 59(5):501. |
[16] |
LIU JR, LU JIE, LI DF, et al.Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children[J].World J Pediatr, 2017, 13(4):321. doi: 10.1007/s12519-017-0014-9 |
[17] |
林志雄, 王开梅, 陈江.不同剂量糖皮质激素辅助治疗小儿难治性肺炎支原体肺炎合并肺外并发症疗效比较[J].中国医院药学杂志, 2017, 3(7):639. |